Argon to pay $362.5M for Angiotech's interventional biz

Argon Medical Devices has agreed to pay $362.5 million to acquire Angiotech Pharmaceuticals' interventional products unit. The cash deal, set to be finalized by the end of next month, covers Angiotech's drainage catheters, biopsy systems and related products.

View Full Article in:

Globe and Mail (Toronto) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN